SVCM
Saturn V Capital Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-59,017
| Closed | -$1.98M | – | 25 |
|
|
2025
Q1 | $1.98M | Sell |
59,017
-108
| -0.2% | -$3.62K | 1% | 20 |
|
|
2024
Q4 | $3.02M | Sell |
59,125
-50,442
| -46% | -$2.58M | 1.18% | 20 |
|
|
2024
Q3 | $5.6M | Sell |
109,567
-370,114
| -77% | -$18.9M | 2% | 19 |
|
|
2024
Q2 | $21.5M | Sell |
479,681
-180,462
| -27% | -$8.08M | 8.12% | 3 |
|
|
2024
Q1 | $30.9M | Sell |
660,143
-126,989
| -16% | -$5.94M | 12.39% | 1 |
|
|
2023
Q4 | $28M | Sell |
787,132
-339,447
| -30% | -$12.1M | 10.72% | 2 |
|
|
2023
Q3 | $33.5M | Buy |
1,126,579
+187,902
| +20% | +$5.59M | 14.02% | 1 |
|
|
2023
Q2 | $16.9M | Buy |
938,677
+197,634
| +27% | +$3.56M | 9.38% | 2 |
|
|
2023
Q1 | $11.9M | Buy |
741,043
+117,224
| +19% | +$1.88M | 8.89% | 2 |
|
|
2022
Q4 | $11.3M | Buy |
+623,819
| New | +$11.3M | 9.41% | 1 |
|